Syrah Resources Critical Minerals Graphite Mining Transaction
November 25, 2024
Cravath represented Syrah Resources Limited (“Syrah”), as sponsor, and its subsidiary, Twigg Exploration & Mining, Limitada, as borrower, in connection with a loan from the United States International Development Finance Corporation (“DFC”). Syrah, together with its subsidiaries, is strategically positioned as the first vertically integrated ex‑China natural graphite active anode material supplier for battery and electric vehicle manufacturers globally. Proceeds of the DFC loan will be used to fund capital requirements at the Balama Graphite Operation in Mozambique, the largest graphite mining and processing operation in the world. Graphite produced at Balama is shipped to global battery anode and industrial customers and is being processed at Syrah’s active anode material facility in Louisiana. DFC’s investment will support Syrah in preparation for increased sales to ex‑China anode customers, bolstering the U.S. supply chain for critical minerals. The transaction closed on November 8, 2024.
The Cravath team included partner Andrew C. Compton and associates April M. Kent and Trevor Lutzow. Brandon D. Holt also worked on this matter.
Related Practices & Industries
People
- Photo
-
-
J.D., 2007, Cornell Law School
-
B.S., 2003, University of Southern Californiamagna cum laude
- New York
Education
Admitted In
Related News
Deals & Cases
November 13, 2024
Just Eat Takeaway.com’s Sale of Grubhub to Wonder
On November 13, 2024, Just Eat Takeaway.com N.V. (“Just Eat Takeaway.com”), one of the world’s leading global online food delivery companies, announced that it has entered into a definitive agreement to sell Grubhub Inc. (“Grubhub”) to Wonder Group, Inc. (“Wonder”) for an enterprise value of $650 million. Grubhub will be transferred with its $500 million of senior notes. Cravath is representing Just Eat Takeaway.com in connection with the transaction.
Deals & Cases
November 04, 2024
DRI Healthcare Trust’s Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat and Equity Investment in KalVista Pharmaceuticals
On November 4, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has acquired a royalty interest in the worldwide net sales of all formulations of sebetralstat, an investigational oral plasma kallikrein inhibitor for the treatment of Hereditary Angioedema, from KalVista Pharmaceuticals ("KalVista") for an aggregate purchase price of up to $179 million, comprised of a $100 million upfront payment, up to $57 million in a sales-based milestone payment and a one-time $22 million optional payment. Additionally, the Trust is making a $5 million investment in KalVista’s common stock in a private placement transaction. Cravath is representing DRI Healthcare Trust in connection with the transaction.
Deals & Cases
October 29, 2024
Gannett Holdings LLC’s Term Loan Facility
Cravath represented Gannett Holdings LLC in connection with its $900 million senior secured term loan facility. Gannett Holdings LLC is a wholly owned subsidiary of Gannett Co., Inc., a leading diversified media company with expansive reach at the national and local level dedicated to empowering and enriching communities. The transaction closed on October 15, 2024.
Deals & Cases
October 29, 2024
Reynolds Consumer Products Inc.’s Revolving Credit Facility
Cravath represented the lead bookrunner in connection with a $700 million revolving credit facility made available to Reynolds Consumer Products Inc. Reynolds Consumer Products Inc. produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally. The transaction closed on October 17, 2024.
